Adamis Pharmaceuticals Corporation ADMP NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

10/100

0/6 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Adamis Pharmaceuticals Corporation (ADMP) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 10/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

10/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

✗

未來

20/100

Analyst consensus

→ Forecast

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

0/100

→ Income

✗

成长

30/100

→ Income

✗

收入

10/100

→ Income

估值概览 — ADMP

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.35

EV/EBITDA0.0

每股数据

EPS (TTM)$-12.24

每股账面价值$0.00

每股营收$2.22

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-85.96	$0.00	$-7.19M	-
2014	$-76.19	$0.00	$-8.16M	-
2015	$-70.71	$0.00	$-13.57M	-
2016	$-77.75	$6.47M	$-19.44M	-300.2%
2017	$-63.06	$13.07M	$-25.54M	-195.4%
2018	$-69.86	$15.09M	$-39.01M	-258.6%
2019	$-38.52	$22.11M	$-29.31M	-132.5%
2020	$-44.57	$16.53M	$-49.39M	-298.8%
2021	$-16.80	$2.21M	$-34.6M	-1566.6%
2022	$-12.24	$4.76M	$-26.2M	-550.9%